Literature DB >> 18571929

Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.

Thota Ganesh1, Jaeki Min, Pahk Thepchatri, Yuhong Du, Lian Li, Iestyn Lewis, Larry Wilson, Haian Fu, Gabriela Chiosis, Raymond Dingledine, Dennis Liotta, James P Snyder, Aiming Sun.   

Abstract

The molecular chaperone Hsp90 plays important roles in maintaining malignant phenotypes. Recent studies suggest that Hsp90 exerts high-affinity interactions with multiple oncoproteins, which are essential for the growth of tumor cells. As a result, research has focused on finding Hsp90 probes as potential and selective anticancer agents. In a high-throughput screening exercise, we identified quinoline 7 as a moderate inhibitor of Hsp90. Further hit identification, SAR studies, and biological investigation revealed several synthetic analogs in this series with micromolar activities in both fluorescent polarization (FP) assay and a cell-based Western blot (WB) assay. These compounds represent a new class of Hsp90 inhibitors with simple chemical structures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571929      PMCID: PMC2553564          DOI: 10.1016/j.bmc.2008.05.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  39 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

2.  Synthesis of a red-shifted fluorescence polarization probe for Hsp90.

Authors:  Kamalika Moulick; Cristina C Clement; Julia Aguirre; Joungnam Kim; Yanlong Kang; Sara Felts; Gabriela Chiosis
Journal:  Bioorg Med Chem Lett       Date:  2006-06-22       Impact factor: 2.823

3.  Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.

Authors:  James H Nettles; Jeremy L Jenkins; Andreas Bender; Zhan Deng; John W Davies; Meir Glick
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

4.  A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells.

Authors:  G Chiosis; M N Timaul; B Lucas; P N Munster; F F Zheng; L Sepp-Lorenzino; N Rosen
Journal:  Chem Biol       Date:  2001-03

5.  Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors.

Authors:  Robert M Immormino; Yanlong Kang; Gabriela Chiosis; Daniel T Gewirth
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

6.  Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues.

Authors:  Swee Y Sharp; Chrisostomos Prodromou; Kathy Boxall; Marissa V Powers; Joanna L Holmes; Gary Box; Thomas P Matthews; Kwai-Ming J Cheung; Andrew Kalusa; Karen James; Angela Hayes; Anthea Hardcastle; Brian Dymock; Paul A Brough; Xavier Barril; Julie E Cansfield; Lisa Wright; Allan Surgenor; Nicolas Foloppe; Roderick E Hubbard; Wynne Aherne; Laurence Pearl; Keith Jones; Edward McDonald; Florence Raynaud; Sue Eccles; Martin Drysdale; Paul Workman
Journal:  Mol Cancer Ther       Date:  2007-04       Impact factor: 6.261

7.  Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.

Authors:  W Xu; E Mimnaugh; M F Rosser; C Nicchitta; M Marcu; Y Yarden; L Neckers
Journal:  J Biol Chem       Date:  2000-11-08       Impact factor: 5.157

Review 8.  Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.

Authors:  L Neckers; T W Schulte; E Mimnaugh
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

9.  Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity.

Authors:  Srinivas R Kasibhatla; Kevin Hong; Marco A Biamonte; David J Busch; Patricia L Karjian; John L Sensintaffar; Adeela Kamal; Rachel E Lough; John Brekken; Karen Lundgren; Roy Grecko; Gregg A Timony; Yingqing Ran; Robert Mansfield; Lawrence C Fritz; Edgar Ulm; Francis J Burrows; Marcus F Boehm
Journal:  J Med Chem       Date:  2007-05-08       Impact factor: 7.446

10.  High-throughput screening fluorescence polarization assay for tumor-specific Hsp90.

Authors:  Yuhong Du; Kamalika Moulick; Anna Rodina; Julia Aguirre; Sara Felts; Raymond Dingledine; Haian Fu; Gabriela Chiosis
Journal:  J Biomol Screen       Date:  2007-10
View more
  5 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

2.  Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.

Authors:  Sherida L Johnson; Li-Hsing Chen; Elisa Barile; Aras Emdadi; Mojgan Sabet; Hongbin Yuan; Jun Wei; Donald Guiney; Maurizio Pellecchia
Journal:  Bioorg Med Chem       Date:  2009-03-26       Impact factor: 3.641

3.  Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay.

Authors:  Thota Ganesh; Pahk Thepchatri; Lian Li; Yuhong Du; Haian Fu; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem Lett       Date:  2008-08-14       Impact factor: 2.823

Review 4.  Cancer and virus leads by HTS, chemical design and SEA data mining.

Authors:  Pahk Thepchatri; Jaeki Min; Thota Ganesh; Yuhong Du; Iestyn Lewis; Serdar Kurtkaya; Andrew Prussia; Lian Li; Blossom Sneed; Richard K Plemper; Haian Fu; Dennis C Liotta; James P Snyder; Raymond Dingledine; Aiming Sun
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

5.  Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.

Authors:  Maryam Abbasi; Hojjat Sadeghi-Aliabadi; Massoud Amanlou
Journal:  Daru       Date:  2017-06-30       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.